Assessing drug promotions Flashcards
“All informational and persuasive activities by
manufacturers and distributors, the effect of which is
to influence the prescription, supply, purchase or use
of medicinal drugs.”
DRUG PROMOTION
“Material or information provided by drug
manufacturers with the ultimate goal of increasing
prescribing or purchasing of medications.”
DRUG PROMOTION
T/F: General public: allowed for OTC medication and
food supplement only
T
Advertisements are regulated by
Ad Standards Council (ASC)
companies can advertise
company name only; company name associated
with BOTH OTC and prescription meds
Loophole exploited
Industry exploits this by masking promotions as
“patient-care oriented”
(IN) VULNERABILITY TO INFLUENCE
Technique: Appeal to pity
DESIRE TO HELP PATIENTS (VIA FREE SAMPLE)
Need to make multiple decisions on patients’
pharmacotherapeutics
DECISION-MAKING SHORTCUTS
Inclusion of flawed information (e.g. exaggerated,
inaccurate, oversimplified, etc.)
MISLEADING INFORMATION
Omission of relevant information
MISLEADING INFORMATION
Distraction with relevant information (red herrings)
MISLEADING INFORMATION
Exploit unconscious influences on health
professionals’ judgment
SALES REPRESENTATIVES
Experts: Dr. X/Sponsored Guideline X
recommends Drug Y
Appeal to Authority
Peers: Drug Y is most frequently
prescribed for condition A
Bandwagon Effect
People we like can be trusted – via
attractive, friendly reps
Building Relationships
get person to agree to successive
statements until desired conclusion is
arrived
Commitment consistency technique
Clinicians come to us
Goes to clinicians
DRUG INDUSTRY
Didactic
ACADEMIA
Interactive
DRUG INDUSTRY
Text-heavy, not visually
engaging, data driven
ACADEMIA
Visually-stimulating, data
driven
DRUG INDUSTRY
Does not engage clinician
perspective
ACADEMIA
Engaged clinician
perspective
DRUG INDUSTRY
Evaluation: minimal
ACADEMIA
Outcome evaluation
DRUG INDUSTRY
Goal: unclear, unstated
ACADEMIA
Goal: behavior change
DRUG INDUSTRY
also known as the “Implementing Guidelines on
the Promotion and Marketing of Prescription
Pharmaceutical Products and Medical Devices”
DOH AO 2015-0053
“To ensure that medical decisions are
made in the best interest of the patients, and that
these are upheld by all stakeholders with the end
goal of improving and promoting the rational use of
prescription pharmaceutical products and
medical devices and safeguarding patient rights and
welfare.”
TLDR
